ARAY: accuray.com Price/Earnings to Growth Multiple

Symbol and logo of brand Accuray, Inc. (ARAY)

The integration of software and hardware from Accuray Incorporated (ARAY) creates deep brand loyalty among medical centers. The average PEG ratio visualizes this dynamic, where the 0.00 metric indicates the asset's valuation relative to earnings growth rates. The business foundation relies on stable liquidity and diversified electronics supply chains, ensuring the uninterrupted shipment of complex therapy systems to clinics.

Price/Earnings to Growth Ratio: Accuray Inc (ARAY) for 07/04/2022 - 11/10/2026
Mass-produced product of Accuray Incorporated

The PEG ratio compares the current P/E market multiple with earnings growth rates, allowing for the determination of an asset's undervaluation relative to its expansion. By analyzing the PEG fair value filter, an investor assesses the extent to which the high precision of Accuray Incorporated (ARAY) CyberKnife systems converts into capitalization, identifying growth potential for the shares at values below one against the backdrop of the company's technological dominance.

Competing companies

ONC (BeiGene Ltd.) - Growth-Adjusted Payback Ratio|PEG Multiple HALO (Halozyme Inc.)|RVMD - Price/Earnings to Growth Multiple|AAPG: Price/Earnings to Growth Multiple|CGON - PEG Multiple|UroGen Pharma (URGN) - Price/Earnings to Growth Ratio|Bicara Therapeutics Inc - Growth-Adjusted Payback Ratio|PSNL (Personalis Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Erasca Oncology ERAS|PEG Multiple DCTH|PEG Multiple ymabs.com (YMAB)|PEG Multiple AURA (Aura Biosciences)|CADL - Price/Earnings to Growth Multiple|SELLAS Life Sciences Group Inc. - PEG Multiple|Actuate Therapeutics Inc (ACTU) - Price/Earnings to Growth Multiple|CTOR (Citius Oncology, Inc.) - Price/Earnings to Growth Multiple|TuHURA Biosciences (HURA) - PEG Multiple|Price/Earnings to Growth Ratio Protara Therapeutics, Inc.|FATE: Growth-Adjusted Payback Ratio|PEG Multiple WHWK|PEG Multiple tscan.com (TCRX)|Champions Oncology, Inc. - Price/Earnings to Growth Multiple|XBiotech Inc (XBIT) - Price to Earnings Adjusted for Growth Rate|CVM: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio OSTX (OS Therapies Inc.)|RADX: PEG Multiple|ARTV - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Adlai Nortye Ltd|Growth-Adjusted P/E Ratio VERU (verupharma.com)|PEG Multiple TPST|Price/Earnings to Growth Multiple xiliotx.com XLO|Price/Earnings to Growth Ratio Renovaro RENB|Mural Oncology PLC (MURA) - Price to Earnings Adjusted for Growth Rate|KAPA - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio OKUR (OnKure Therapeutics Inc)|w2.cytomed.sg (GDTC) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio CRIS (Curis)|Price/Earnings to Growth Ratio Apollomics Inc.|Price to Earnings Adjusted for Growth Rate Tharimmune Corporation THAR|Price/Earnings to Growth Ratio Advanced Biomed Inc (ADVB)|GNPX (genprex.com) - Growth-Adjusted Payback Ratio|PEG Multiple CLDI (Calidi Biotherapeutics, Inc.)|PEG Multiple Sunshine Biopharma Inc. SBFM|XBIO: Price/Earnings to Growth Multiple|Salarius Pharma - Company Value to Earnings Growth Ratio|PPBT: PEG Multiple|Price to Earnings Adjusted for Growth Rate American Oncology Network, Inc. (AONC)|BGNE (BeiGene) - PEG Multiple|Growth-Adjusted P/E Ratio CKPT (Checkpoint Therapeutics Inc.)|PEG Multiple ELEV|PEG Multiple icadmed.com (ICAD)|Price/Earnings to Growth Ratio Ikena Oncology IKNA|Growth-Adjusted Payback Ratio NTBL|Viracta - PEG Multiple|MOR - PEG Multiple|NAYA (NAYA Bio) - Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Ascentage (AAPGV)